Davide Corti

Vir Biotechnology (Switzerland) — Switzerland

Medicine · Health Sciences

92h-index38.6kcitations290works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(129), Animal Virus Infections Studies(58), Viral gastroenteritis research and epidemiology(47), Monoclonal and Polyclonal Antibodies Research(39), COVID-19 Clinical Research Studies(38)

Publications280 total

Potent neutralization of Marburg virus by a vaccine-elicited antibody
Nature·2025· 1 citedOpen Access
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Nature Immunology·2025· 2 citedOpen Access
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
2025Open Access
Potent neutralization of Marburg virus by a vaccine-elicited monoclonal antibody
2025Open Access
Irradiation tests of the OBDTv1 board at CHARM
Journal of Instrumentation·2025· 1 citedOpen Access
Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection
JHEP Reports·2025· 4 citedOpen Access
Potent efficacy of a NA-targeting antibody against a broad spectrum of H5N1 influenza viruses
2025Open Access
The engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor positive cells leading to activation of HBV-specific T cells
2025Open Access
Author Correction: Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
Communications Medicine·2025Open Access
Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
Communications Medicine·2024· 7 citedOpen Access
Design of customized coronavirus receptors
Nature·2024· 15 citedOpen Access
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
UNC Libraries·2024· 1 citedOpen Access
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
npj Vaccines·2024· 12 citedOpen Access
PET/CT Targeted Tissue Sampling Reveals Intravenously Administered HGN194 IgG1 Affects HIV Distribution after Rectal Exposure
AIDS Research and Human Retroviruses·2024Open Access
Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes
European Journal of Immunology·2024· 2 citedOpen Access
Author response for "Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes"
2024
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Nature Communications·2024· 15 citedOpen Access
Author response for "Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes"
2024
Broadly neutralizing antibodies against emerging delta-coronaviruses
2024Open Access
Comparative Disease Burden and Treatment Response of Influenza and SARS-CoV-2 Infections: A Real-World Data Study
2024Open Access
page 1 of 14Next →

Frequent Co-authors

Antonio Lanzavecchia(27), David Veesler(21), Elisabetta Cameroni(19), Herbert W. Virgin(19), Alexandra C. Walls(18), Gyorgy Snell(17), John E. Bowen(17), Dora Pinto(14), Federica Sallusto(14), Anna De Marco(13), Laura E. Rosen(13), Amalio Telenti(12), Matteo Samuele Pizzuto(12), Siro Bianchi(11), Stefano Jaconi(11), Katja Culap(11), Luca Piccoli(11), Martina Beltramello(10), Fabrizia Zatta(10), Barbara Guarino(10)